Michael Shetzline, CMO, SVP, Head-Res&Drug at IRONWOOD PHARMACEUTICALS INC (IRWD), sold 77,236 shares at $15.24 ($1.2M) on 2024-02-12, disclosed to the SEC on 2024-02-14.
Open-market sale of $1.2M IRWD by CMO, SVP, Head-Res&Drug. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.24 | 38,618 | $589K | 50.0% |
| 2 | $15.24 | 38,618 | $589K | 50.0% |
| Total | $15.24 avg | 77,236 | $1.2M | 100% |
| Filing → |
| IRWD | SELL | 2024-05-22 | $208K | — | Filing → |
| IRWD | SELL | 2023-05-24 | $209K | — | Filing → |
| IRWD | SELL | 2023-03-01 | $385K | — | Filing → |